ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

13.35

+0.06 (0.45%)

At close: May 13, 2025, 4:00 PM

12.60

-0.75 (-5.62%)

Pre-market: May 14, 2025, 7:57 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Needle-free Intranasal	30.00K	Log In
Needle-free Intranasal Growth	-97.72%	Log In

Revenue by Geography

Fiscal year is January - December.